Replies to post #6340 on MATRIX Penny Stocks

[Capt_Nemo]

CDIK, I see why you would warm up to it omni, We have a DMI cross and an upper bollie bust, haaaaaaaaaaaaaaaaaaa

[Capt_Nemo]

CDIK, 7 s-8's since 2001
State the number of shares outstanding of each of the issuer's classes of
common equity, as of November 10, 2003: 156,824,951.


Coronado Industries Inc Total Results: 74 NEXT

Limit Forms: All FormsS110K10Q10K & 10QRegistration StatementsRegistration TerminationProxies, Information StatementsQuarterly ReportsAnnual ReportsInsider TradingTrust Indenture Act FilingsMiscellaneous13F RelatedN-30 Related8K RelatedWilliams Act Limit Keyword:


FORM TYPE FORM DESCRIPTION DATE FILED

10QSB 10QSB, Quarterly report filed by small businesses 11/14/2003


10QSB 10QSB, Quarterly report filed by small businesses 08/19/2003


NT 10-Q NT 10-Q, Notification that form type 10-Q will be submitted late 08/14/2003


S-8 S-8, Securities offered to employees pursuant to employee benefit plans 07/28/2003
This one only Proposed Proposed
Title of Maximum Maximum
Securities Amount Offering Aggregate Amount of
to be to be Price Offering Registration
Registered Registered Per Share Price Fee
--------------------------------------------------------------------------------
Common Stock,
$.001 par value 8,600,000 $.06 $516,000 $41.74
================================================================================


10QSB 10QSB, Quarterly report filed by small businesses 05/20/2003


NT 10-Q NT 10-Q, Notification that form type 10-Q will be submitted late 05/16/2003


S-8 S-8, Securities offered to employees pursuant to employee benefit plans 05/07/2003


10KSB 10KSB, Annual report filed by small businesses 04/15/2003


NT 10-K NT 10-K, Notification that form 10-K will be submitted late 04/01/2003


S-8 S-8, Securities offered to employees pursuant to employee benefit plans 01/27/2003


S-8 POS S-8 POS, Post-effective amendment to an S-8 filing 12/10/2002


S-8 S-8, Securities offered to employees pursuant to employee benefit plans 12/02/2002


10QSB 10QSB, Quarterly report filed by small businesses 11/13/2002


10QSB 10QSB, Quarterly report filed by small businesses 08/14/2002


S-8 S-8, Securities offered to employees pursuant to employee benefit plans 06/18/2002


10QSB 10QSB, Quarterly report filed by small businesses 05/15/2002


10KSB40 10KSB40, Optional form for annual and transition reports of small business issuers 03/29/2002


S-8 S-8, Securities offered to employees pursuant to employee benefit plans 01/18/2002


10QSB 10QSB, Quarterly report filed by small businesses 11/14/2001


S-8 S-8, Securities offered to employees pursuant to employee benefit plans 10/19/2001


http://knobias.10kwizard.com/files.php

[Churak]

CDIK...how much of a story do you want? I have been a stuckholder for 3+ years. Recently bounced off .065 after breaking resistance at about .08. They haven't had any sales in about 7 years. They have one product ie a device called PNT used to treat glaucoma. They were allegedly a hair away from FDA in 2001 plus NVS walked away from an Option Agreement to distribute PNT after tying up CDIK for 1.5 years. CDIK has now abandoned FDA & instead is going for 2A to distribute in Europe. They allegedly have a deal with an Italian Distributor that no one can find any info on ie EuPharmed. 2A is "expected" any day now. IF they get that, expect a pop. Oh yeah, per the chart, the spike in June was after the announcement that 2 ex-NVS dudes joined the management team of CDIK and the emphasis then switched from the US to Europe in terms of getting sales. This weekend, management of CDIK is attending a conference to pitch PNT to attending Ophthamologists from around the world. o\s shares have gone from about 20 mil to 156 mil currently. They have registered & then pulled 3 reverse splits with their transfer agent per the t\a. I expect dilution before the end of the Q 4 if no 2A by then & no cash in as they traditionally issue shares in lieu of salaries & convert debt to shares @ 50% of the trading price prior to year end. Do I sound negative? Sorry...been forked over many many years with this one. I have sold off most of my position but still hold some "just in case". Management & insiders hold approx 60% of the o\s. No shareholders meeting ever been held. Like I said, IF they get 2A, there will be a spike and that allegedly is "any day now". Financial statements are pathetic ie less than $100,000 in assets of which $37,50 is deferred compensation. They are not required to file form 4s; only 144s and managment has sold millions of shares in the last 2 years.

[chessnut]

cdik filling for 11/15/03Coronado Industries, Inc.


N MARKET GUIDE INC
G
K Copyright (c) 2003, Market Guide Inc., All rights reserved
G TABLE OF CONTENTS
L
Ous;CDIK[MG]/2 L<<< Company Description
Ous;CDIK[MG]/3 L<<< Quarterly Summary
Ous;CDIK[MG]/4 L<<< Company To Industry Ratio Comparison
Ous;CDIK[MG]/5 L<<< Share Ownership & Price Performance
Ous;CDIK[MG]/6 L<<< Capitalization, Officers & Address
Ous;CDIK[MG]/7 L<<< Annual Income Statements
Ous;CDIK[MG]/8 L<<< Annual Income Statements - Continued
Ous;CDIK[MG]/9 L<<< Quarterly & Year To Date Income Statements
Ous;CDIK[MG]/10 L<<< Annual & Quarterly Balance Sheets
Ous;CDIK[MG]/11 L<<< Annual & Year To Date Statement of Cash Flows
G
G
G
OComplete Financials: G June 2003 OExchange G OTC
O G OFY END G DEC
L ISSUE DATA (11/14/03) PER SHARE DATA RATIOS
OPrice $ G 0.09 OEPS (TTM) $ G -0.02 OP/E (TTM) G NM
O52W High $ G 0.14 ODiv. Rate $ G 0.00 OYield G NA %
O52W Low $ G 0.01 OBook Value $ G 0.00 OPrice/Book G NM
OShrs Out G 152.63 Mil OCash $ G 0.00 OROE (TTM) G NM %
OFloat G 48.80 Mil ORev (TTM) $ G NA OROA (TTM) G-2,182.41 %
OMon. Vol G 8.84 Mil O G OCurr. Ratio G 0.01
OBeta G -2.68 O G OLT Dbt/Eqty G NM
O BRIEF: G Coronado Industries, Inc., through Ophthalmic
G International, Inc., manufactures and markets a vacuum
G fixation device with a patented designed suction ring that
G reats Open Angle & Pigmentary glaucoma. For the 6 months
G ended 6/30/03, the Company reported no revenue. Net loss
G fell 24% to $439K. Revenues reflect the absence of product
G sales. Lower loss reflects decreased salaries and wages
G and decreased FDA expense.
G

G L HISTORICAL QUARTERLY RESULTS ($000)
LREVENUE 1999 2000 2001 2002
O1st Qtr MAR G 74 0 0
O2nd Qtr JUN G 0 0 0
O3rd Qtr SEP G 0 12 0 0
O4th Qtr DEC G 0 0 0 0
LEPS (U.S. Dollars per share)
O1st Qtr MAR G 0.000 -0.020 -0.010
O2nd Qtr JUN G -0.010 -0.010 -0.010
O3rd Qtr SEP G -0.010 -0.010 -0.010 -0.010
O4th Qtr DEC G -0.010 -0.060 -0.010 -0.010
G
G 9/96, chg. name from Logical Computer Services of NY, Ltd.
G 11/96, acq. Ophthalmic Int'l & Amer. Glaucoma Institute in a
G reverse merger for 16.8M Common shs. FY'97 Q's reclass.
G
L DIVIDENDS EMPLOYEES
O Last Dividend Decl. G $ NA O # Employees G 5
O Last Div Ex-Date G NA O Sales/Employee (TTM) G NM
O Last Div Pay Date G NA O Net. Income/Empl.(TTM G) NM
LCOMPANY COMPARISON TO THE MEDICAL SUPPLY AND S&P 500 AGGREGATES
LVALUATION RATIOS: COMPANY INDUSTRY S&P 500
OP/E Ratio G NM 31.83 26.25
ODividend Yield G NA 1.34 2.05
OPrice to Tangible Book G -21.25 11.95 7.69
OPrice to Book G NM 7.09 4.65
OPrice to Free Cash Flow G -85.00 41.65 31.53
LGROWTH STATISTICS:
O3 Yr Rev Growth G NM 12.12 8.19
O3 Yr EPS Growth G NM 20.04 10.16
O3 Yr Div Growth G NM 13.17 8.60
OReinvestment Rate G 100.00 77.08 69.80
LPROFITABILITY RATIOS:
ONet Profit Margin G NM 14.53 12.11
OReturn on Equity G NM 23.23 17.65
OInterest Coverage G -24.71 32.23 12.49
LFINANCIAL STRENGTH RATIOS:
OCurrent Ratio G 0.01 2.38 1.71
OLT Debt to Equity G NM 0.24 0.80
OTotal Debt to Equity G NM 0.31 1.09
L INSTITUTIONAL OWNERSHIP INSIDER TRADING (Prev. 6 months)
G O % Shares Out. Owned G NA % ONet Insider Trades G NA
O # of Institutions G NA O# Buy Transactions G NA
O Total Shs Held G NA Mil O# Sell Transactions G NA
O 3 Mo. Net Purch. G NA Mil ONet Shares Bought G NA Mil
O 3 Mo. Shs Purch. G NA Mil O# Shares Bought G NA Mil
O 3 Mo. Shs Sold G NA Mil O# Shares Sold G NA Mil
G
O 4 Week Price % Change G 6.3% O 4 Week Rel. Price % Change G 5.1%
O 13 Week Price % Change G 41.7% O 13 Week Rel. Price % Change G 33.6%
O 26 Week Price % Change G 183.3% O 26 Week Rel. Price % Change G 154.7%
O 52 Week Price % Change G 70.0% O 52 Week Rel. Price % Change G 47.3%
OYTD Week Price % Change G 183.3% OYTD Week Rel. Price % Change G 137.3%
G
G
LMARKET MAKERS: G GVRC NITE SCHB PRGM WIEN HRZG SLKC HILL FLTT
G
G
G
G
OEQUITY: GCommon Stock $.001 Par, 7/03, 400M auth., 152,630,159 issd.
GInsiders control approx. 68%. Initial Public Offering:
G3/90, 5,000 shares @ $4.50 by the Company. 9/96, 1-for-5
Greverse stock split. 9/97, Co. sold 282K shs. @ $1.25 in a
Gprivate placement. FY'96 fncls. are restated.
G
G
OOFFICERS: G G. Richard Smith, Chmn./Secy., Gary R. Smith,
GPres./Treas. TRANSFER AGENT: Olde Monmouth Stock Transfer
GCo., Inc., NJ. Company incorporated 1989 in Nevada. Direct
Ginquiries to: G. Richard Smith, Chmn./Secy.
G
O ADDRESS & PHONE NUMBERS
GCoronado Industries, Inc.
G16929 East Enterprise Drive
GSuite 202
GFountain Hills, AZ 85268
GPHONE: [phone]
G FAX: [phone]
G
LANNUAL INCOME STATEMENT ($000)
L 12M 12/31/99 12M 12/31/00 12M 12/31/01 12M 12/31/02
ORevenues G 0 0 0 0
OProduct G 46 12 0 0
OPatient G 28 0 0 0
O Total Revenue G 74 12 0 0
OCost of Patient Rev. G 0 0 0 0
OCost Product Rev. G 174 0 0 0
OGeneral/Administrat. G 0 0 0 0
OSalaries / Wages G 300 1,764 885 752
OPublic Relations G 131 1,146 201 34
OOther Operating G 591 417 257 470
OFDA Expense G 100 176 282 180
O Total Expenses G 1,296 3,503 1,625 1,436
O Operating Income G -1,222 -3,491 -1,625 -1,436





LANNUAL INCOME STATEMENT ($000) (Contd.)
L 12M 12/31/99 12M 12/31/00 12M 12/31/01 12M 12/31/02
O Operating Income G -1,222 -3,491 -1,625 -1,436
OInterest Expense G -36 -95 -106 -43
OOther, Net G 86 5 -48 -2
O Income Before Taxes G -1,172 -3,581 -1,779 -1,481
OIncome Taxes G 0 0 0 0
O Income After Taxes G -1,172 -3,581 -1,779 -1,481
O Pri/Bas EPS Ex. XOrd G -0.036 -0.102 -0.039 -0.021
O Pri/Bas EPS In. XOrd G -0.036 -0.102 -0.039 -0.021
OPrimary/Basic Avg Sh G 32,208.15 35,055.50 46,173.59 71,730.60
OCommon Dividends/Shr G 0.0000 0.0000 0.0000 0.0000








LSELECTED INCOME STATEMENT ITEMS ($000)
L QUARTERS YEAR TO DATE
L 3M 06/30/02 3M 06/30/03 6M 06/30/02 6M 06/30/03
ORevenue G 0 0 0 0
OOperating Expenses G 252 274 566 415
O Operating Income G -252 -274 -566 -415
ONon-Operating Income G -1 0 1 0
ONon-Operating Expenses G -8 -17 -15 -24
O Income Before Taxes G -261 -291 -580 -439
OIncome Taxes G 0 0 0 0
OAdjustments to Income G 0 0 0 0
O Inc. for Primary EPS G -261 -291 -580 -439
O Pri/Bas EPS Ex. XOrd G -0.004 -0.002 -0.009 -0.004
ODisc Opns + Xord Items G 0 0 0 0
O Pri/Bas EPS In. XOrd G -0.004 -0.002 -0.009 -0.004
OPrimary/Basic Avg Sh G 69,064.27 144,284.71 68,757.68 113,608.82
O Dilutd EPS Excl XOrd G -0.004 -0.002 -0.009 -0.004
O Dilutd EPS Incl XOrd G -0.004 -0.002 -0.009 -0.004
OCommon Dividends/Shr G 0.000 0.000 0.000 0.000

LSELECTED BALANCE SHEET ITEMS ($000)
L YEAR ENDING QUARTER ENDING
L 12/31/01 12/31/02 06/30/02 06/30/03
OCash & ST Investments G 22 2 15 5
OReceivables G 0 0 0 0
O Total Current Assets G 22 2 15 5
OLT Investments G 0 0 0 0
OFixed Assets G 24 14 19 12
O Total Assets G 95 40 79 78
OAccounts Payable G 38 156 39 109
OST Debt & Curr LTD G 0 481 335 400
O Total Current Liab. G 42 834 565 704
OLT Debt & Cap Leases G 230 0 0 0
O Total Liabilities G 272 834 565 704
OPreferred Stock G 0 0 0 0
OCommon/Paid In Capital G 8,872 9,737 9,142 10,344
ORetained Earnings G -9,049 -10,530 -9,628 -10,969
O Total Equity G -177 -793 -486 -625
OShares Outstanding G 67,837 81,236 69,399 151,895

LSELECTED STMT OF CASH FLOWS - INDIRECT METHOD ($000)
L ANNUAL YEAR TO DATE
L 12M 12/31/01 12M 12/31/02 6M 06/30/02 6M 06/30/03
ONet Income G -1,780 -1,481 -579 -439
ODepreciation & Amort. G 15 32 6 5
ONon Cash Items G 2,256 866 271 606
O Total Operating CF G -251 -270 -111 86
OCapital Expenditures G -1 0 0 -3
O Total Investing CF G 21 0 0 -3
ODividends Paid G 0 0 0 0
OSale (Purch.) of Stock G 14 0 0 0
ONet Borrowings G 237 251 105 -81
O Total Financing CF G 251 251 105 -81
OExchange Rate Effect G 0 0 0 0
ONet Change In Cash G 20 -19 -7 3
OOper CF-Cap Exp-Div Pd G -252 -270 -111 83



KCopyright (c) 2003, Market Guide Inc., All rights reserved
G

Nov-15-2003 14:56 GMT
Symbols:
US;CDIK DE;CIQ DE;CIQF DE;CIQX
Source B Market Guide

[Churak]

Almost forget re CDIK. If SORE is on the ask, chances are that insiders are selling.